Literature DB >> 17703390

A randomized controlled trial on use of propofol alone versus propofol with midazolam, ketamine, and pentazocine "sedato-analgesic cocktail" for sedation during ERCP.

W C Ong1, D Santosh, S Lakhtakia, D Nageshwar Reddy.   

Abstract

BACKGROUND AND AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) requires adequate patient sedation in order to carry out the procedure successfully. Propofol sedation is being increasingly used during ERCP. There are limited data to evaluate the efficacy of synergistic agents with propofol for sedation during ERCP. The aims of the current study were: (i) to compare patient sedation and tolerance during ERCP using either propofol alone or a "sedato-analgesic cocktail" for induction, along with propofol for maintenance, and (ii) to prospectively compare complications related to both sedation regimens. PATIENTS AND METHODS: This was a double-blind, randomized controlled trial with patients receiving either intravenous propofol alone (Group A) or a sedato-analgesic cocktail (midazolam, ketamine, and pentazocine plus propofol) (Group B) for induction; all patients received propofol for maintenance. Patient sedation and tolerance were assessed using 100-mm visual analog scales (VAS).
RESULTS: A total of 199 patients undergoing ERCP were randomized (Group A, n = 104 vs. Group B, n = 95). Clinical characteristics were similar in both groups. Patient tolerance VAS scores were higher in Group B when assessed independently by both endoscopist ( P = 0.002) and anesthetist ( P = 0.001). The differences in scores occurred predominantly in younger patients. The mean propofol requirement was 192 mg in Group A and 131 mg in Group B; the mean difference was 61 mg (95%CI 40-82 mg). Patients reported equivalent levels of satisfaction with both sedation regimens. On multivariate analysis, "cocktail" use ( P = 0.013) and increasing age ( P = 0.027) significantly improved patient tolerance during ERCP. Caution during "cocktail" induction is required as transient oxygen desaturation occurs.
CONCLUSION: During ERCP, propofol with a sedato-analgesic cocktail for induction results in improved patient tolerance compared with propofol alone, particularly in younger patients. Generalizations from this study to the Western world and to different cultural groups require further study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703390     DOI: 10.1055/s-2007-966725

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  10 in total

1.  Carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography reduces bowel gas volume but does not affect visual analogue scale scores of suffering: a prospective, double-blind, randomized, controlled trial.

Authors:  Masaki Kuwatani; Hiroshi Kawakami; Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Taiki Kudo; Hiroaki Yamato; Nobuyuki Ehira; Shin Haba; Kazunori Eto; Mototsugu Kato; Masahiro Asaka
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

2.  Balanced propofol sedation versus propofol monosedation in therapeutic pancreaticobiliary endoscopic procedures.

Authors:  Tae Hoon Lee; Chang Kyun Lee; Sang-Heum Park; Suck-Ho Lee; Il-Kwun Chung; Hyun Jong Choi; Sang Woo Cha; Jong Ho Moon; Young Deok Cho; Young Hwangbo; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2012-05-22       Impact factor: 3.199

3.  Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures.

Authors:  Sachin Wani; Riad Azar; Christine E Hovis; Robert M Hovis; Gregory A Cote; Matthew Hall; Lawrence Waldbaum; Vladimir Kushnir; Dayna Early; Daniel K Mullady; Faris Murad; Steven A Edmundowicz; Sreenivasa S Jonnalagadda
Journal:  Gastrointest Endosc       Date:  2011-12       Impact factor: 9.427

4.  BIS Targeted Propofol Sparing Effects of Dexmedetomidine Versus Ketamine in Outpatient ERCP: A Prospective Randomised Controlled Trial.

Authors:  Seshadri Ramkiran; Sadasivan S Iyer; Sudhindra Dharmavaram; Chadalavada Venkata Rama Mohan; Avinash Balekudru; Radhika Kunnavil
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  Cocktail sedation containing propofol versus conventional sedation for ERCP: a prospective, randomized controlled study.

Authors:  Phonthep Angsuwatcharakon; Rungsun Rerknimitr; Wiriyaporn Ridtitid; Pradermchai Kongkam; Sahadol Poonyathawon; Yuwadee Ponauthai; Sakolkan Sumdin; Pinit Kullavanijaya
Journal:  BMC Anesthesiol       Date:  2012-08-09       Impact factor: 2.217

6.  The dexmedetomidine "augmented" sedato analgesic cocktail: An effective approach for sedation in prolonged endoscopic retrograde cholangio-pancreatography.

Authors:  Sandip Mukhopadhyay; Mausumi Niyogi; Joydip Sarkar; Basabdatta Samanta Mukhopadhyay; Swapan Kumar Halder
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Apr-Jun

7.  Assessing the safety of physician-directed nurse-administered propofol sedation in low-risk patients undergoing endoscopy and colonoscopy.

Authors:  Dharshan Sathananthan; Edward Young; Garry Nind; Biju George; Angelie Ashby; Sharon Drummond; Kasia Redel; Neville Green; Rajvinder Singh
Journal:  Endosc Int Open       Date:  2017-02

8.  Comparative Evaluation of Dexmedetomidine versus Midazolam as Premedication to Propofol Anesthesia in Endoscopic Retrograde Cholangiopancreatography.

Authors:  Geetanjali Pushkarna; Pankaj Sarangal; Varun Pushkarna; Ruchi Gupta
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

9.  The Sedative and Propofol-Sparing Effect of Dexmedetomidine and Midazolam as Premedicants in Minor Gynecological Day Care Surgeries: A Randomized Placebo-Controlled Study.

Authors:  Anita Kumari; Arvinder Pal Singh; Jyoti Vidhan; Ruchi Gupta; Jonny Dhawan; Jasleen Kaur
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun

10.  Propofol vs traditional sedatives for sedation in endoscopy: A systematic review and meta-analysis.

Authors:  Aureo Augusto de Almeida Delgado; Diogo Turiani Hourneaux de Moura; Igor Braga Ribeiro; Ahmad Najdat Bazarbashi; Marcos Eduardo Lera Dos Santos; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Gastrointest Endosc       Date:  2019-12-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.